Meningococcal Vaccination Service — ACWY Conjugate and B Vaccines
⏱️ 1-Minute Key Takeaways
- Rapid and Severe Progression: Invasive meningococcal disease can prove fatal or cause permanent disability (such as limb amputation or hearing loss) within 24 hours.
- Dual-Track Protection: Because no single vaccine covers all serogroups, receiving both the ACWY conjugate vaccine and the group B vaccine is necessary for complete immunisation.
- Broad Age Suitability: Suitable for infants from 2 months of age, children, adolescents, and individuals preparing for travel, studying abroad, or living in institutional settings.
- Not Included in Government Subsidised Schemes: This vaccine is not part of the Hong Kong Childhood Immunisation Programme and requires proactive arrangement through private healthcare services.
- Advance Preparation for Travel or Study: Travellers to epidemic regions or students preparing for overseas boarding school or university should plan and vaccinate ahead of time.
📋 Summary:
Meningococcal infections, including meningococcal meningitis and septicaemia, present rapid and severe clinical courses that pose significant health risks to infants and adolescents. Our clinic offers Hong Kong-registered ACWY conjugate vaccines (such as Nimenrix and MenQuadfi) alongside group B meningococcal vaccines (such as Bexsero).
Meningococcus is a severe, acute bacterial infection primarily transmitted via respiratory droplets or close personal contact with infected individuals or asymptomatic carriers. Children attending school and interacting in close proximity face a higher risk of cross-infection.
Early symptoms closely resemble those of a common cold or mild viral illness (such as fever and fatigue), making them easily overlooked. However, once the bacterium invades the bloodstream (causing meningococcal septicaemia) or the meninges surrounding the brain and spinal cord (causing meningococcal meningitis), the clinical condition can deteriorate rapidly within 24 hours, potentially leading to fatality or severe long-term sequelae including cognitive impairment, deafness, or tissue necrosis requiring amputation. As the meningococcal vaccine is not part of the Hong Kong Childhood Immunisation Programme, families can seek private medical guidance proactively.
What is the Difference Between ACWY and Group B Vaccines and How Do They Complement Each Other?
The key comparisons are outlined below:
| Characteristics | Nimenrix (ACWY) | MenQuadfi (ACWY) | Bexsero (Group B) |
|---|---|---|---|
| Covered Serogroups | A, C, W-135, Y | Group B | |
| Starting Age | 6 weeks | 12 months (1 year) | 2 months |
| Primary Series Dose | • 6 weeks to <6 months: 2 doses (interval: 2 months) • 6 months to <12 months: 1 dose • ≥12 months: 1 dose |
• 12–23 months: 2-dose series (at least 3 months apart) • ≥2 years: 1 dose |
• 2–5 months: 2 doses (interval: ≥2 months) OR 3 doses (interval: ≥1 month) • 6–11 months: 2 doses (interval: ≥2 months) • 12–23 months: 2 doses (interval: ≥2 months) • ≥2 years: 2 doses (interval: ≥1 month) |
| Booster | Recommended | High risk group | Recommended |
| Clinical Significance | Protects against global circulating and travel-associated high-risk strains | Targets aggressive Group B strains prevalent locally and in Western countries | |
| Vaccination Strategy | Complementary: To achieve complete protection in infants and young children, you can receive both ACWY and group B vaccines. | ||
Who is at High Risk and What Are the Early Symptoms of Infection?
- Transmission Routes: Spread through respiratory droplets or close physical contact. Asymptomatic carriage is common among healthy individuals.
- High-Risk Groups:
- Infants and young children aged 0 to 5 years with immature immune systems (with the highest incidence seen in infants aged 0 to 3 months)
- Adolescents and individuals residing in dormitories or boarding schools
- Immunocompromised individuals (such as those with asplenia)
- Travellers frequently visiting mainland China, overseas countries, or epidemic regions
- Key Clinical Manifestations:
- Meningococcal Septicaemia: Sudden onset of high fever, myalgia, joint pain, hypotension, and shock, frequently accompanied by characteristic non-blanching purpuric rashes (purpura).
- Meningococcal Meningitis: High fever, severe headache, neck stiffness, vomiting, photophobia, and altered mental state.
Is the Meningococcal Vaccine Safe and What Are the Common Side Effects?
These vaccines generally exhibit a favourable safety profile and good tolerability, though temporary post-vaccination reactions may occur:
- Common Mild Reactions: Injection-site pain, erythema, swelling, or induration. Some infants may experience transient low-grade pyrexia, lethargy, or irritability, which typically resolve spontaneously within 24 to 48 hours.
🚫 Who Should NOT Get the Meningococcal Vaccine?
- The meningococcal vaccine should not be given to individuals who:
- Have had a life-threatening allergic reaction to a previous dose of meningococcal vaccine or any component of the vaccine.
- Have a history of severe allergic reaction (anaphylaxis) to any component of the vaccine, including diphtheria toxoid or tetanus toxoid carrier proteins (depending on the formulation).
- Have an acute, moderate or severe febrile illness (vaccination should be deferred until recovery).
- Have a history of Guillain-Barré Syndrome (GBS) (should consult a doctor before receiving ACWY vaccines).
- Are pregnant or breastfeeding (should discuss risks and benefits with their healthcare provider).
Frequently Asked Questions
Q: Why is receiving only the ACWY vaccine insufficient?
Meningococcal disease is caused by several different serogroups. The ACWY vaccine protects against serogroups A, C, W, and Y, whilst the group B vaccine specifically targets serogroup B. Because group B accounts for a significant proportion of invasive cases locally and globally, doctors generally recommend receiving both vaccines to ensure comprehensive immunological protection.
Q: How many doses are required for infants and children?
The number of doses depends on the child's age at the start of vaccination and the specific vaccine brand chosen. For instance, certain ACWY conjugate vaccines require only a single dose for individuals aged one year or older, whereas infants starting earlier may require a multi-dose primary schedule followed by a booster. Please consult our clinical team for a tailored schedule.
Q: What should I do if my child develops a fever after vaccination?
A mild fever or injection-site soreness is a common, expected immune response indicating that the body is building antibodies. Parents may administer age-appropriate antipyretic medication as advised by a doctor and ensure the child remains well-hydrated and rests. If the fever persists or unusual drowsiness occurs, please contact the clinic promptly.
Q: Do adults or students preparing to study abroad need vaccination?
Yes. Adolescents and university students living in close quarters such as halls of residence are at an increased risk of infection. Many overseas educational institutions strongly recommend or mandate proof of meningococcal vaccination. Adults travelling to high-risk regions or with specific occupational exposures should also consult a doctor.
Q: Can the meningococcal vaccine be given with other vaccines?
Yes. Meningococcal ACWY and Group B vaccines can be administered at the same visit as other routine vaccines, including the 5-in-1/6-in-1 combination vaccines, pneumococcal vaccines, and HPV vaccines, using separate injection sites. Please consult our doctor for a personalised schedule.
Q: Who should NOT get the meningococcal vaccine?
The vaccine should not be given to individuals who have had a severe allergic reaction (anaphylaxis) to a previous dose of any meningococcal vaccine or to any vaccine component, including diphtheria toxoid. Individuals with a history of Guillain-Barré Syndrome (GBS) should consult their doctor before receiving ACWY vaccines. Pregnant or breastfeeding women should discuss the risks and benefits with their doctor.
Q: What are the common side effects of the meningococcal vaccine?
Common side effects are mild and temporary, including pain, redness, or swelling at the injection site, mild fever, fatigue, irritability (in infants), and loss of appetite. For Bexsero, local reactions such as extensive swelling may be more common. Serious allergic reactions are extremely rare.
📚 Data Sources
⚠️ Medical Disclaimer
This article is for informational and educational purposes only and does not constitute medical advice. Vaccine selection should be made in consultation with a registered physician. Please consult your doctor for personalised recommendations.
Get In Touch
For any enquiry, please call +852 3420 6622, Whatsapp +852 5228 0810, or info@marinamedical.hk
